Aims: Oxidative stress may contribute to the development of chronic pancreatitis (CP). The enzymes manganese superoxide dismutase 2 (MnSOD, SOD2) and catalase (CAT) counteract free radical activity within the mitochondria and the cytosol. Moreover, CAT activity contributes to the transformation of ethanol to acetaldehyde, a toxic intermediate product of ethanol metabolism, which has been associated with pancreatic damage. Common functional polymorphisms have been described in the MnSOD gene [rs4880, NM_000636.3:c.47 T > C, alanine (ALA) to valine (Val)] and in the CAT promoter region [rs1001179, NG_013339.1:g.4760 C > T]. We investigated whether these polymorphisms are associated with alcoholic CP. Methods: We genotyped 470 patients with alcoholic CP for these MnSOD and CAT polymorphisms. We also analysed these variants in 357 healthy control subjects, and in an additional control group of 113 individuals with non-alcoholic CP. We used the age at onset of CP as marker of disease severity and investigated whether different genotypes are associated with different ages at onset. In patients with alcoholic CP, we investigated whether an interaction exists between smoking behaviour and genotypes by comparing genotype distributions in smokers and non-smokers. Results: We did not observe significant differences of genotype frequencies between patient groups and controls. In patient groups, we did not find significant differences in the ages at onset © The Author 2017. Medical Council on Alcohol and Oxford University Press. All rights reserved.
INTRODUCTION
Chronic pancreatitis (CP) represents an inflammatory disease of the pancreas that is characterized by repeated episodes of acute pancreatitis, intractable abdominal pain, progressive fibrotic destruction of the organ with loss of pancreatic exocrine and endocrine function (Majumder and Chari, 2016) . Several genetic variants have been identified that are associated with the development of non-alcoholic CP (Majumder and Chari, 2016) . Genetic factors most likely also influence the expression of alcoholic CP, but these factors remain to be identified.
All aerobic organisms generate reactive oxygen species (ROS) during the metabolism of oxygen, and these oxygen intermediates are indispensable for normal cellular function (Li et al., 2015) . However, high levels of these oxygen radicals are potentially toxic to the cells and may result in protein modification, cellular membrane disruption, destruction of nucleic acids in DNA and mitochondrial damage (Li et al., 2015) . Thus, it has been proposed that the tissue damage during CP may result from uncontrolled free radical activity (Braganza, 1998) , and several investigations support this assumption (Bhardwaj and Yadav, 2013) .
In the cell, mitochondria represent the main source of ROS (Shigenaga et al., 1994) . The mitochondria are protected from oxidative stress by the mitochondrial enzyme manganese superoxide dismutase (MnSOD, SOD2), which catalysers the dismutation of superoxide radicals to hydrogen peroxide, which is subsequently converted to water by the antioxidant enzymes glutathione peroxidase and catalase (CAT) (Wallace, 1999) . Moreover, CAT activity contributes to transformation of ethanol to acetaldehyde, a toxic intermediate product of ethanol metabolism, that has also been associated with pancreatic damage (Apte et al., 2000 (Apte et al., , 2006 . Thus, genetic variations in these enzymes may predispose to the development of pancreatic inflammation.
The enzyme MnSOD is encoded by nuclear DNA and synthesized with a mitochondrial targeting sequence that enables its transport into the mitochondria (Wispe et al., 1989) . Subsequently, the targeting sequence is cleaved, and the protein is incorporated into the mitochondrial matrix (Wallace, 1999; Degoul et al., 2001) . In the MnSOD gene, a functional genetic variation in the codon 16 at the −9 amino acid position of the mitochondrial targeting sequence [rs4880, NM_000,636.3:c.47 T > C, alanine (ALA) to valine (Val)] has been described that enhances the translocation of the protein into the mitochondria and that increases the concentration of active MnSOD in the presence of an Ala/Ala-sequence (Shimoda-Matsubayashi et al., 1996; Sutton et al., 2003) . In the promoter region of the CAT gene, a common functional polymorphism has been described at position −330 [rs1001179, NG_013,339.1:g.4760 C > T, previously erroneously reported at position −262 in most of the earlier published papers] that is associated with different protein binding patterns and enzymatic activity depending on the genetic variant at this position (Forsberg et al., 2001) .
These genetic alterations in the MnSOD and CAT genes may result in an increased free radical activity and contribute to the development of CP. Thus, the aims of the present study were, first, to investigate whether these genetic variants are associated with the development of alcoholic CP, and, second, whether these variants predispose to an earlier age at onset of the disease.
MATERIAL AND METHODS

Patients
In the entire study, we investigated 940 individuals for the polymorphisms rs4880 (NM_000,636.3:c.47 T > C) in the MnSOD gene and rs1001179 (NG_013,339.1:g.4760 C > T) in the promoter region of the CAT gene. Whole blood was collected from patients and controls.
In detail, we studied 583 patients with CP and 357 control individuals. The patients were recruited at the participating institutions in Mannheim, Germany (n = 154); Leipzig, Germany (n = 290); Helsinki, Finland (n = 46); and Cluj-Napoca, Romania (n = 93). The controls were randomly selected blood donors from the participating institutions in Mannheim, Germany (n = 200), Helsinki, Finland (n = 63) and Cluj-Napoca, Romania (n = 94).
Diagnosis of CP was based on histological tissue examination in patients that underwent surgical interventions or on two or more of the following findings: presence of a history of recurrent acute pancreatitis or recurrent abdominal pain typical for CP, pancreatic calcifications and/or pancreatic ductal irregularities revealed by endoscopic retrograde pancreaticography, computed tomography imaging, magnetic resonance imaging of the pancreas and/or pathological sonographic findings.
The onset of disease was defined as the period of first clinical symptoms of CP, e.g. first episode of acute pancreatitis, onset of abdominal pain or onset of symptoms of exocrine pancreatic insufficiency.
Alcoholic pancreatitis was diagnosed in individuals presenting with at least one of the following criteria: (i) patient self-report of excessive alcohol use as cause of the disease; (ii) patient self-report of a history of chronic alcohol intake of at least 80 g per day for males or 40 g per day for females, for more than 2 years; or (iii) patient selfreport of lower amounts of alcohol consumption with other evidence of alcoholism (such as external reports from family members, friends or other doctors, external patient records, or patient self-report of worry about drinking, eye-opener drinking in the morning, amnesia due to blackouts, or the feeling of the need to cut down on drinking).
Non-alcoholic pancreatitis was diagnosed in the absence of criteria for alcoholic pancreatitis.
The data on past ethanol consumption and the clinical presentation were based on research records and/or physician's history and/ or completion of a detailed questionnaire by the patient. Data on smoking behaviour were only available as 'smoker' or 'non-smoker' without further informations.
Mutational analysis
DNA was isolated from EDTA-anticoagulated blood using a commercial system (QIAamp Blood DNA Mini Kit; Qiagen, Hilden, Germany). Patients and controls were genotyped for the single nucleotide polymorphism (SNP) in the MnSOD gene [rs4880, c.47 C > T, alanine (ALA) to valine (Val)] and the SNP in the promoter region of the CAT gene [rs1001179] by means of allelic discrimination. Analysis was performed by using predesigned TaqMan SNP genotyping assays (rs4880 assay ID: C_8,709,053_10; rs1001179 assay ID: C_11,468,118_10; Applied Biosystems Inc., Foster City, CA, USA) on an ABI 7000 Real-Time PCR System (Applied Biosystems). Briefly, in these assays, two unlabelled PCR primers and two allele-specific fluorogenic probes are used that are labelled with a different colour reporter dye at the 5′ end. The allele-specific probes are hybridized to the DNA template, and cleavage results in fluorescence emission from the reporter dyes. Analysis of fluorescence was performed by using end point detection and the SDS software of the ABI 7000 System (Applied Biosystems).
Correlation of genotypes with age at onset and smoking behaviour
We used the age at onset of CP as a marker of disease severity. In the cohorts of patients with alcoholic and non-alcoholic CP, we investigated whether different genotypes are associated with different mean ages at onset of disease. In patients with alcoholic CP, we determined a possible interaction of smoking behaviour with MnSOD and CAT genotypes by comparison of the genotype distributions in smokers and non-smokers.
Statistical analysis
We compared the results for genotype frequencies of the different polymorphisms between different patient cohorts and control populations by using contingency table analysis and chi-square-test. We compared the ages of disease onset in different patient groups by one-way analysis of variance (one-way ANOVA). We performed testing for deviation of Hardy-Weinberg equilibrium in all patient and control cohorts. A P < 0.05 was considered significant.
Ethical requirements
The study was approved by the institutional review boards at the Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; at the University of Leipzig, Leipzig, Germany; at the University Central Hospital, Helsinki, Finland and at the University of Medicine and Pharmacy, Cluj-Napoca, Romania. All patients gave written informed consent.
RESULTS
We observed 470 patients with alcoholic CP (n = 470/583; 80.6%; n = 410 males, n = 60 females) and 113 patients with nonalcoholic CP (n = 113/583; 19.4%; n = 51 males, n = 62 females). Information on nicotine consumption were available in 510 patients (n = 510/583; 87.5%). The age at onset of the disease was available in 573 patients (n = 573/583, 98.3%).
We did not observe significant differences between the genotype distributions of the rs4880 polymorphism in the MnSOD gene between patients with alcoholic CP and controls (Table 1 , P = 0.6814, Chi-square-test) or patients with non-alcoholic CP and controls (Table 2 , P = 0.1499, Chi-square-test). We did not detect significant differences between the genotype distributions of the rs1001179 polymorphism in the promoter region of the CAT gene between patients with alcoholic CP and controls (Table 1 , P = 0.2798, Chi-square-test) or patients with non-alcoholic CP and controls (Table 2 , P = 0.3583, Chisquare-test).
We did not observe significant differences between the genotype distributions of the MnSOD or CAT polymorphisms between the patient cohort from Germany and the smaller patient cohorts from Finland and Romania (each P > 0.05, Chi-square-test).
We did not observe significant differences between patients with alcoholic CP (n = 470) and patients with non-alcoholic CP (n = 113) in the genotype distributions of the CAT polymorphism (P = 0.9240, Chi-square-test) and the MnSOD polymorphism (P = 0.2387, Chisquare-test).
We performed further comparisons of genotype counts homozygous for a given allele with the combined counts of the remaining genotypes between patients with alcoholic CP and controls (Table 1B and D) , between the entire cohort of patients with non-alcoholic CP and controls (Table 2B and D), and between German patients with non-alcoholic CP and German controls (Table 2B and D) . Again, these calculations did not reveal statistically significant differences between the different groups of genotypes (each P > 0.05, Chi-square-test; Table 1B and D; Table 2B and D).
We did not detect an interaction between these polymorphisms in patients with alcoholic CP (P = 0.3624, Chi-square-test) or in patients with non-alcoholic CP (P = 0.7422, Chi-square-test).
In the total cohort, the distribution of both variants were in Hardy-Weinberg equilibrium.
In the two cohorts of patients with alcoholic and non-alcoholic CP, we did not reveal significant differences between the mean ages at onset of disease for the different genotypes of the two polymorphisms (P > 0.05, one-way ANOVA) (Table 3) .
In patients with alcoholic CP, we did not observe significant differences between smokers and non-smokers with regard to the genotype distribution of the MnSOD variant (P = 0.2967, chisquare-test) or the CAT variant (P = 0.2729, chi-square-test) (Table 4) .
DISCUSSION
Several lines of evidence suggest that oxidative stress is involved in the development of CP (Bhardwaj and Yadav, 2013) . Increased levels of lipid peroxidation products and changes in glutathione metabolism were detected in pancreatic tissue from patients with CP suggesting an enhanced generation of ROS (Schoenberg et al., 1995) . A decreased antioxidative capacity was detected in patients with alcoholic and non-alcoholic CP (Morris-Stiff et al., 1999; Verlaan et al., 2006; Girish et al., 2011) . A recent meta-analysis of studies on antioxidant therapy for pain control in CP revealed a significant benefit of antioxidant therapy over placebo medication (Rustagi and Njei, 2015) . In experimental studies with rats, acute and chronic alcohol consumption increased markers of oxidative stress in pancreatic tissue or pancreatic secretions (Altomare et al., 1996; Iimuro et al., 1996; Norton et al., 1998a Norton et al., , 1998b Grattagliano et al., 1999) .
The observation of elevated oxidative stress markers in pancreatic tissue in the absence of histological damage supported the assumption that oxidative stress occurs rather as a primary phenomenon than as part of an inflammatory response (Norton et al., 1998b) . Of note, mitochondria represent the main source of ROS in the cell (Shigenaga et al., 1994) , and damage to mitochondria has also been observed in human alcoholic subjects (Wieland and Lauterburg, 1995) . In rats, chronic ethanol feeding induced mitochondrial damage in the pancreas, including swelling and formation of giant mitochondria, fragmentation of the internal membranes, damaged cristae and functional impairment (Darle et al., 1970; Tandler et al., 1996; Grattagliano et al., 1999; Li et al., 2001) .
The enzyme MnSOD provides protection from ROS in mitochondria and catalysers the dismutation of superoxide radicals to hydrogen peroxide that is subsequently converted to water by catalases and peroxidases. The MnSOD protein is synthesized in the cytoplasm as a precursor with a mitochondrial targeting sequence that appears to be essential for the effective transport of the enzyme into the mitochondria (Wispe et al., 1989) . During the processing to the mature enzyme, the targeting sequence is removed (Degoul et al., 2001) . The cleavage of the targeting sequence and the transport into the mitochondria is affected by a genetic dimorphism in the MnSOD mitochondrial targeting sequence (Shimoda-Matsubayashi et al., 1996; Sutton et al., 2003) . Thus, impaired mitochondrial uptake of MnSOD may reduce the antioxidative capacity in the mitochondria with subsequent alcohol-related organ damage (Degoul et al., 2001) .
The antioxidant enzyme CAT also supports the transformation of ethanol to acetaldehyde (Forsberg et al., 2001) . In the pancreas, alcohol is metabolized by oxidative and non-oxidative pathways (Haber et al., 1998; Gukovskaya et al., 2002) . Ethanol metabolism by pancreatic acinar cells and its metabolites such as acetaldehyde or fatty acid ethyl ester contribute to pancreatic damage (Apte et al., 2000; Criddle et al., 2004) . Of note, pancreatic stellate cells regulate the fibrotic destruction of the pancreas in CP, and the activation of these cells is mediated by ethanol, its metabolite acetaldehyde, oxidative stress and cytokines (Apte et al., 2006) . A functional polymorphism in the promoter region of the CAT gene has been associated with different protein binding patterns and enzymatic activity depending on the genetic variant at this position (Forsberg et al., 2001) .
These observations support the assumption that an increased generation of ROS after ethanol consumption may directly result from ethanol metabolism or from ethanol-induced reduction of Comparison of genotype distributions between patients with alcoholic CP and control individuals from the different countries (Table A, results MnSOD;  Table C , results CAT).
Comparison of genotype counts homozygous for a given allele with a combined count of the remaining genotypes between patients with alcoholic CP and controls (Table B, results MnSOD; Table D , results CAT).
Statistical comparisons were performed between the entire patient cohort and the total control group. The P-values reflect comparisons between genotype frequencies or groups of different genotypes. *Chi-square-test.
pancreatic antioxidative capacity, and that functional genetic variations in the MnSOD or CAT genes may predispose to the development of alcohol-related organ damage. Several studies revealed an association of the MnSOD polymorphism with alcoholic liver disease (Degoul et al., 2001; Huang et al., 2016; Roy et al., 2016) . However, these results were not confirmed in another study (Stewart et al., 2002) . In this context, a preliminary study with 75 patients did not find an association of the MnSOD and CAT polymorphisms with alcoholic CP (Rahman et al., 2005) , and a subsequent analysis with 305 patients also excluded an association of the MnSOD polymorphism with alcoholic CP (Osterreicher et al., 2007) . However, the inconsistent results with the MnSOD variant in alcoholic liver disease and the incomplete analysis of the CAT promoter variant warranted another study in individuals with alcoholic CP. The similarities in the genotype frequencies between our representative cohort of patients with alcoholic CP and the control Comparison of genotype distributions between patients with non-alcoholic CP and control individuals from the different countries (Table A, results MnSOD;  Table C , results CAT).
Comparison of genotype counts homozygous for a given allele with a combined count of the remaining genotypes between patients with non-alcoholic CP and controls (Table B, results MnSOD; Table D , results CAT).
Statistical comparisons were performed, first, between the entire patient cohort and the total control group; and second, due to the low numbers of patients with non-alcoholic CP in the Finnish and Romanian cohorts, separately between the German patient cohort and the German control cohort.
The P-values reflect comparisons between genotype frequencies or groups of different genotypes. *Chi-square-test.
groups suggest that the investigated polymorphisms in the MnSOD and CAT genes are not associated with the development of alcoholic CP. The observed similar mean ages at onset of disease with all different genotypes further support this assumption. In an additional analysis of the patients with alcoholic CP, we did not find an association of these variants with smoking behaviour. However, a limitation of our analysis is that we did not investigate individuals with alcohol abuse, but without CP. Another limitation is that associations between diseases and polymorphisms in oxidative stress genes are difficult to establish since these enzymes are part of a complex detoxification system. In rats, ethanol consumption increased MnSOD activity, while glutathione peroxidase and catalase activities were decreased (Polavarapu et al., 1998) . Thus, overexpression of genes may compensate deficiencies of other enzymes.
In conclusion, the investigated polymorphisms have no impact on the development of alcoholic CP. Further genetic investigations may identify interactions between genes that predispose to the development of alcoholic CP. In patients with alcoholic and non-alcoholic CP, the mean ages at onset of disease were similar with the different MnSOD and CAT genotypes. The Pvalues reflect comparisons between the mean ages at onset with the different genotypes. SD = standard deviation. **One-way ANOVA. The distributions of the MnSOD and CAT genotypes were similar in smokers and non-smokers with alcoholic CP. The P-values reflect comparisons between genotype frequencies in smokers and non-smokers. *Chi-square-test.
